Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/5/26 19:52 | 1/2/26 | ATHA | Health | BioPrd | Biological Products, (No Diag | San Martin Javier | WA | O | CHIEF ME | 1 | S.d | -11 | 6.88 | 0 | -2 | 10 | D | |||||||||||||||
1/5/26 19:51 | 1/2/26 | ATHA | Health | BioPrd | Biological Products, (No Diag | Litton Mark James | WA | DO | P,CEO | 1 | S.d | -18 | 6.88 | 0 | -3 | 43 | D | |||||||||||||||
1/5/26 19:50 | 1/2/26 | ATHA | Health | BioPrd | Biological Products, (No Diag | Renninger Robert | WA | O | CFO | 1 | S.d | -2 | 6.88 | 0 | 0 | 13 | D | |||||||||||||||
1/5/26 19:50 | 1/2/26 | ATHA | Health | BioPrd | Biological Products, (No Diag | Church Kevin | WA | O | Chief Sc | 1 | S.d | -6 | 6.88 | 0 | -1 | 21 | D | |||||||||||||||
1/5/26 19:49 | 1/2/26 | ATHA | Health | BioPrd | Biological Products, (No Diag | Worthington Mark | WA | O | GC,CCO | 1 | S.d | -6 | 6.88 | 0 | -1 | 14 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |